IL163718A0 - Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy - Google Patents
Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapyInfo
- Publication number
- IL163718A0 IL163718A0 IL16371803A IL16371803A IL163718A0 IL 163718 A0 IL163718 A0 IL 163718A0 IL 16371803 A IL16371803 A IL 16371803A IL 16371803 A IL16371803 A IL 16371803A IL 163718 A0 IL163718 A0 IL 163718A0
- Authority
- IL
- Israel
- Prior art keywords
- compositions
- methods
- treating gastrointestinal
- gastrointestinal toxicity
- toxicity induced
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36021102P | 2002-02-26 | 2002-02-26 | |
| PCT/US2003/006333 WO2003072061A2 (en) | 2002-02-26 | 2003-02-26 | Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL163718A0 true IL163718A0 (en) | 2005-12-18 |
Family
ID=27766201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16371803A IL163718A0 (en) | 2002-02-26 | 2003-02-26 | Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20040110687A1 (es) |
| EP (1) | EP1485118A2 (es) |
| JP (1) | JP2005524650A (es) |
| KR (1) | KR20040094745A (es) |
| CN (1) | CN1642568A (es) |
| AU (1) | AU2003219971A1 (es) |
| CA (1) | CA2477231A1 (es) |
| CO (1) | CO5611158A2 (es) |
| IL (1) | IL163718A0 (es) |
| MA (1) | MA27187A1 (es) |
| MX (1) | MXPA04008290A (es) |
| NO (1) | NO20044064L (es) |
| RU (1) | RU2004128444A (es) |
| WO (1) | WO2003072061A2 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7498309B2 (en) | 2003-11-29 | 2009-03-03 | Sangstat Medical Corporation | Pharmaceutical compositions for bioactive peptide agents |
| WO2006031614A2 (en) * | 2004-09-10 | 2006-03-23 | Tosk, Inc. | Reduced toxicity methotrexate formulations and methods for using the same |
| CN101804197B (zh) * | 2010-05-21 | 2012-05-23 | 魏华 | 一种用于癌症骨转移的药物组合物及其用途 |
| MX2016003092A (es) | 2013-09-13 | 2016-11-14 | Soligenix Inc | Peptidos y analogos novedosos para uso en el tratamiento de mucositis oral. |
| US11311598B2 (en) | 2013-09-13 | 2022-04-26 | Soligenix, Inc. | Peptides and analogs for use in the treatment of oral mucositis |
| CN111533802B (zh) * | 2020-05-09 | 2022-05-17 | 清华大学深圳国际研究生院 | S-腺苷同型半胱氨酸人工完全抗原、制备方法及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5385888A (en) * | 1987-03-20 | 1995-01-31 | The Regents Of The University Of California | Class I MHC modulation or surface receptor activity |
| US5453359A (en) * | 1988-06-13 | 1995-09-26 | American Biogenetic Sciences, Inc. | Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
| US6162434A (en) * | 1995-05-03 | 2000-12-19 | Sangstat Medical Corporation | Cytomodulating peptide for inhibiting lymphocyte activity |
| US5753625A (en) * | 1995-05-12 | 1998-05-19 | Sangstat Medical Corporation | Treatment for inhibiting the progression of autoimmune disease |
| BR9808529B1 (pt) * | 1997-04-11 | 2010-10-05 | oligopeptìdeo. | |
| US6696545B1 (en) * | 1997-04-11 | 2004-02-24 | Sangstat Medical Corporation | Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation |
-
2003
- 2003-02-26 RU RU2004128444/14A patent/RU2004128444A/ru not_active Application Discontinuation
- 2003-02-26 IL IL16371803A patent/IL163718A0/xx unknown
- 2003-02-26 WO PCT/US2003/006333 patent/WO2003072061A2/en not_active Application Discontinuation
- 2003-02-26 AU AU2003219971A patent/AU2003219971A1/en not_active Abandoned
- 2003-02-26 EP EP03716258A patent/EP1485118A2/en not_active Withdrawn
- 2003-02-26 KR KR10-2004-7013390A patent/KR20040094745A/ko not_active Application Discontinuation
- 2003-02-26 CN CNA038071843A patent/CN1642568A/zh active Pending
- 2003-02-26 MX MXPA04008290A patent/MXPA04008290A/es not_active Application Discontinuation
- 2003-02-26 US US10/376,647 patent/US20040110687A1/en not_active Abandoned
- 2003-02-26 JP JP2003570808A patent/JP2005524650A/ja active Pending
- 2003-02-26 CA CA002477231A patent/CA2477231A1/en not_active Abandoned
-
2004
- 2004-09-20 MA MA27866A patent/MA27187A1/fr unknown
- 2004-09-23 CO CO04094999A patent/CO5611158A2/es not_active Application Discontinuation
- 2004-09-24 NO NO20044064A patent/NO20044064L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1485118A2 (en) | 2004-12-15 |
| WO2003072061A3 (en) | 2004-07-08 |
| NO20044064L (no) | 2004-11-18 |
| WO2003072061A2 (en) | 2003-09-04 |
| CN1642568A (zh) | 2005-07-20 |
| MXPA04008290A (es) | 2004-11-26 |
| KR20040094745A (ko) | 2004-11-10 |
| MA27187A1 (fr) | 2005-01-03 |
| JP2005524650A (ja) | 2005-08-18 |
| CO5611158A2 (es) | 2006-02-28 |
| US20040110687A1 (en) | 2004-06-10 |
| AU2003219971A1 (en) | 2003-09-09 |
| RU2004128444A (ru) | 2005-06-10 |
| CA2477231A1 (en) | 2003-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1583542E (pt) | Composições e métodos para terapia de combinação antiviral | |
| IL172194A0 (en) | Methods and compositions for treating amyloid-related diseases | |
| EP1468118A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| GB0208696D0 (en) | Fabric treatment composition | |
| AU2003275126A8 (en) | Hemiasterlin derivatives for treating resistant tumors | |
| EP1572118A4 (en) | METHOD AND COMPOSITIONS FOR TREATING CANCER WITH 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 216 | |
| IL163876A0 (en) | Therapeutic methods and compositions involving isovlav-3-ene and isoflavan structures | |
| GB0303609D0 (en) | Novel therapeutic method and compositions | |
| ZA200500431B (en) | Medicinal composition for treating arteriosclerosis | |
| EP1626711A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF CANCER | |
| EP1677805A4 (en) | TREATMENT OF PANCREATIC CANCER | |
| IL163718A0 (en) | Methods and compositions for treating gastrointestinal toxicity induced by cytoablative therapy | |
| IL166062A0 (en) | Compositions and methods for therapeutic treatment | |
| AU2003298708A8 (en) | Gpc99 and gpc99a: methods and compositions for treating cancer | |
| AU2003291730A8 (en) | Methods and compositions for treating neurodegenerative diseases | |
| AU2003275433A8 (en) | Compositions and methods for treating pain | |
| GB0221157D0 (en) | Novel treatment | |
| GB0327050D0 (en) | Therapeutic methods compositions and uses | |
| AU2003285883A8 (en) | Methods and compositions for determining risk of treatment toxicity | |
| AU2003214606A8 (en) | Compositions and methods for treating mdma-induced toxicity | |
| GB0303600D0 (en) | Novel therapeutic method and compositions | |
| AU2003295604A8 (en) | Gpc15: methods and compositions for treating cancer | |
| GB0223325D0 (en) | Treating cancer | |
| GB0225815D0 (en) | Soil Treatment | |
| GB0305699D0 (en) | Therapeutic compositions and methods |